We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Biodegradable Sensor Helps Monitor Serious Health Conditions

By HospiMedica International staff writers
Posted on 29 Jan 2018
Print article
Image: A biodegradable piezoelectric pressure sensor can monitor a wide range of medical conditions before dissolving safely (Photo courtesy of Thanh Duc Nguyen /UConn).
Image: A biodegradable piezoelectric pressure sensor can monitor a wide range of medical conditions before dissolving safely (Photo courtesy of Thanh Duc Nguyen /UConn).
A new study describes how a biodegradable pressure sensor can monitor chronic lung disease, brain swelling, and other medical conditions before dissolving harmlessly in the body.

Under development at the University of Connecticut (UConn; Storrs, USA), the new sensor is made of two layers of piezoelectric poly-D,L-lactide (PDLLA) polymer film sandwiched between miniature molybdenum electrodes, and then encapsulated in layers of polylactic (PLA). The piezoelectric PLLA film emits a small electrical charge when pressure is applied to it, allowing it to precisely measure pressures between 0–18 kPa, and maintain reliable performance levels for a period of up to four days in an aqueous environment.

In a proof of concept study, the researchers implanted the PLLA piezoelectric sensor in the abdominal cavity of a mouse in order to monitor the pressure of diaphragmatic contraction and respiratory rate. The implanted sensor was hardwired to an external signal amplifier, which transmitted the enhanced electrical signals to an oscilloscope. After four days, the sensor broke down into its individual organic components. Immune response was confined to minor inflammation in the surrounding tissues, which returned to normal after four weeks. The study was published on January 16, 2018, in Proceedings of the National Academy of Sciences (PNAS).

“We are very excited because this is the first time these biocompatible materials have been used in this way,” said senior author Thanh Duc Nguyen, PhD, of the UConn Institute of Materials Science. “Medical sensors are often implanted directly into soft tissues and organs. Taking them out can cause additional damage. We knew that if we could develop a sensor that didn't require surgery to take it out, that would be really significant.”

“There are many applications for this sensor. Let's say the sensor is implanted in the brain; we can use biodegradable wires and put the accompanying non-degradable electronics far away from the delicate brain tissue, such as under the skin behind the ear, similar to a cochlear implant,” concluded Dr. Nguyen. “Then it would just require a minor treatment to remove the electronics, without worrying about the sensor being in direct contact with soft brain tissue.”

Piezoelectricity, discovered in 1880 by French physicists Jacques and Pierre Curie, is a reversible effect in crystals that describes the internal generation of an electrical charge resulting from a mechanical force. For example, lead zirconate titanate crystals will generate measurable piezoelectricity when their static structure is deformed by about 0.1% of the original dimension. Conversely, those same crystals will change about 0.1% of their static dimension when an external electric field is applied to the material. The inverse piezoelectric effect is used in the production of ultrasonic sound waves.

Related Links:
University of Connecticut


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
1.5T MRI System
uMR 670

Print article

Channels

Surgical Techniques

view channel
Image: NICO SPECTRA is only hand-held technology delivering blue light closer to target to enhance tissue fluorescence (Photo courtesy of NICO Corporation)

Handheld Device for Fluorescence-Guided Surgery a Game Changer for Removal of High-Grade Glioma Brain Tumors

Grade III or IV gliomas are among the most common and deadly brain tumors, with around 20,000 cases annually in the U.S. and 1.2 million globally. These tumors are very aggressive and tend to infiltrate... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more